KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Current Taxes (2022 - 2024)

Historic Current Taxes for Acadia Pharmaceuticals (ACAD) over the last 3 years, with Q2 2024 value amounting to $8.5 million.

  • Acadia Pharmaceuticals' Current Taxes changed N/A to $8.5 million in Q2 2024 from the same period last year, while for Jun 2024 it was $8.5 million, marking a year-over-year change of. This contributed to the annual value of $8.7 million for FY2023, which is 221034.48% up from last year.
  • As of Q2 2024, Acadia Pharmaceuticals' Current Taxes stood at $8.5 million.
  • In the past 5 years, Acadia Pharmaceuticals' Current Taxes registered a high of $8.7 million during Q4 2023, and its lowest value of $377000.0 during Q4 2022.
  • Moreover, its 3-year median value for Current Taxes was $8.5 million (2023), whereas its average is $6.7 million.
  • Within the past 5 years, the most significant YoY rise in Acadia Pharmaceuticals' Current Taxes was 221034.48% (2023), while the steepest drop was 221034.48% (2023).
  • Quarter analysis of 3 years shows Acadia Pharmaceuticals' Current Taxes stood at $377000.0 in 2022, then soared by 2210.34% to $8.7 million in 2023, then dropped by 2.92% to $8.5 million in 2024.
  • Its last three reported values are $8.5 million in Q2 2024, $7.6 million for Q1 2024, and $8.7 million during Q4 2023.